T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equifax
EFX
|
+$715M |
| 2 |
Linde
LIN
|
+$549M |
| 3 |
Xcel Energy
XEL
|
+$547M |
| 4 |
Intercontinental Exchange
ICE
|
+$533M |
| 5 |
AbbVie
ABBV
|
+$503M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$948M |
| 2 |
TE Connectivity
TEL
|
+$756M |
| 3 |
Yum! Brands
YUM
|
+$685M |
| 4 |
Becton Dickinson
BDX
|
+$666M |
| 5 |
Ingersoll Rand
IR
|
+$648M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.49% |
| 2 | Healthcare | 22.34% |
| 3 | Financials | 13.96% |
| 4 | Industrials | 11.89% |
| 5 | Consumer Discretionary | 11.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
JELD-WEN Holding
JELD
$169M
| $21M | 0.02% |
2,179,640
+41,313
| +2% | +$401K |
|
452
Upwork
UPWK
$1.04B
| $21M | 0.02% |
2,007,962
-459,625
| -19% | -$5.67M |
|
|
VMEO
453
DELISTED
Vimeo
VMEO
| $20.6M | 0.02% |
6,009,452
-4,862,058
| -45% | -$18.8M |
|
|
LL
454
DELISTED
LL Flooring Holdings, Inc.
LL
| $20.4M | 0.02% |
3,637,435
-1,843
| -0.1% | -$12.9K |
|
|
MORF
455
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $20.3M | 0.02% |
758,846
+25,782
| +4% | +$705K |
|
456
Children's Place
PLCE
$53.4M
| $20.3M | 0.02% |
+557,205
| New | +$20.9M |
|
|
HLVX
457
DELISTED
HilleVax
HLVX
| $20.3M | 0.02% |
1,211,322
+111,322
| +10% | +$2.01M |
|
458
American Public Education
APEI
$848M
| $19.8M | 0.02% |
1,610,340
-231,775
| -13% | -$2.87M |
|
459
Voya Financial
VOYA
$9.09B
| $19.7M | 0.02% |
320,655
+10,004
| +3% | +$641K |
|
460
Advantage Solutions
ADV
$418M
| $19.5M | 0.01% |
374,301
+20,644
| +6% | +$1.3M |
|
461
MacroGenics
MGNX
$273M
| $19.3M | 0.01% |
2,876,728
-5,281
| -0.2% | -$29K |
|
462
Cal-Maine
CALM
$3.89B
| $19.3M | 0.01% |
354,213
-565,556
| -61% | -$32.7M |
|
463
NerdWallet
NRDS
$625M
| $18.9M | 0.01% |
1,965,399
+175,422
| +10% | +$1.97M |
|
464
Ultragenyx Pharmaceutical
RARE
$2.62B
| $18.6M | 0.01% |
402,521
-2,204,910
| -85% | -$86.7M |
|
465
Intellia Therapeutics
NTLA
$1.67B
| $18.6M | 0.01% |
533,617
-852
| -0.2% | -$40.5K |
|
466
Hercules Capital
HTGC
$3.14B
| $18.3M | 0.01% |
1,381,750
-210,708
| -13% | -$2.86M |
|
467
Blue Bird Corp
BLBD
$2.06B
| $18.1M | 0.01% |
1,687,436
-177,011
| -9% | -$1.78M |
|
468
Douglas Emmett
DEI
$1.99B
| $18.1M | 0.01% |
1,152,028
+172,698
| +18% | +$2.87M |
|
|
RETA
469
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $18.1M | 0.01% |
475,222
+135
| +0% | +$4.65K |
|
470
Korn Ferry
KFY
$4.27B
| $17.6M | 0.01% |
348,630
+65,413
| +23% | +$3.48M |
|
471
Denali Therapeutics
DNLI
$4.04B
| $17.6M | 0.01% |
633,358
+211,001
| +50% | +$6.28M |
|
|
NXRT
472
NexPoint Residential Trust
NXRT
$637M
| $17.5M | 0.01% |
402,035
+102,297
| +34% | +$4.57M |
|
473
RGC Resources
RGCO
$222M
| $17.5M | 0.01% |
792,155
-1,002
| -0.1% | -$22.3K |
|
|
DAY
474
DELISTED
Dayforce
DAY
| $16.8M | 0.01% |
261,116
-610
| -0.2% | -$38.3K |
|
475
LegalZoom.com
LZ
$942M
| $16.7M | 0.01% |
2,157,671
-4,435
| -0.2% | -$38.5K |
|
Similar funds
T. Rowe Price Investment Management's Q4 2022 Portfolio in Review
As of Q4 2022, T. Rowe Price Investment Management held 577 positions worth $130B, up 4.1% from $125B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Investment Management's Q4 2022 filing shows 38 new, 261 increased, 232 reduced and 36 closed positions. Its largest new stake was Xcel Energy: 8,228,100 shares worth $577M. The largest sale was Alphabet (Google) Class C, an estimated $948M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Investment Management's largest Q4 2022 buy was Xcel Energy: 8,228,100 shares worth $577M.
- T. Rowe Price Investment Management added most to Equifax in Q4 2022, an estimated $715M increase.
- T. Rowe Price Investment Management's biggest Q4 2022 reduction was TE Connectivity, cutting an estimated $756M.
- T. Rowe Price Investment Management fully exited Alphabet (Google) Class C in Q4 2022, selling an estimated $948M.
- T. Rowe Price Investment Management's ten largest holdings make up 16% of its $130B portfolio in Q4 2022.
- T. Rowe Price Investment Management opened 38 new positions and closed 36 in Q4 2022.
- T. Rowe Price Investment Management's portfolio value rose 4.1% quarter-over-quarter to $130B.
Based on T. Rowe Price Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.